Cingulate (CING) Debt Ratio (2023 - 2025)
Cingulate's (CING) quarterly Debt Ratio came in at 0.08 in Q4 2025, down 53.4% YoY from 0.16 in Q4 2024, and up 3.13% on a QoQ basis from 0.07 in Q1 2025.
Cingulate (CING) Debt Ratio (2023 - 2025) Analysis & Trends
Cingulate (CING) has 3 years of Debt Ratio data on file, last reported at 0.08 in Q4 2025.
- Quarterly Debt Ratio fell 53.4% year-over-year to 0.08 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.08 (down 53.4% YoY) and the FY2025 annual result came in at 0.08, down 53.4% from the prior year.
- Debt Ratio advanced to 0.08 in Q4 2025, from 0.07 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.6 in Q4 2023 to a low of 0.07 in Q1 2025.
- A 3-year average of 0.25 and a median of 0.16 in 2024 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2024 — Debt Ratio plunged 72.74% — and 2025, when it plunged 53.4%.
- Tracing CING's Debt Ratio over 3 years: stood at 0.6 in 2023, then sank by 72.74% to 0.16 in 2024, then sank by 53.4% to 0.08 in 2025.
- The last three Debt Ratio figures came in at 0.08 (Q4 2025), 0.07 (Q1 2025), and 0.16 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.26 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.47 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.03 |
| 10 | Cingulate | 70.68 Mn | 70.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.08 |
| Mar 31, 2025 | 0.07 |
| Dec 31, 2024 | 0.16 |
| Dec 31, 2023 | 0.60 |
| Sep 30, 2023 | 0.36 |